RTX vs STAA · P/E 36, rev $88.60B vs rev $313.9M
RTX Corporation (RTX) versus STAAR Surgical Company (STAA) — a side-by-side from cached financials, not a winner call.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
STAAR Surgical Company (STAA) is a medical instruments & supplies company listed on NASDAQ.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Latest reported STAA revenue for 2024-12-27 was $313.9M. Net income was -$20.2M. Revenue was down 2.6% from 2023-12-29 to 2024-12-27. STAA currently screens at market cap $1.45B.
RTX currently screens at market cap $259.34B and trailing P/E 36.2. STAA currently screens at market cap $1.45B.
Not investment advice. Open the RTX and STAA stock pages for the full models.
Not investment advice.